Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-02-22 @ 7:25 AM
Study NCT ID:
NCT03884192
Status:
UNKNOWN
Last Update Posted:
2019-03-21
First Post:
2019-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC
Sponsor:
Shandong Cancer Hospital and Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-11
First Submit QC Date:
None
Study First Post Date:
2019-03-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-19
Last Update Post Date:
2019-03-21
Last Update Post Date Type:
ACTUAL